BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36324612)

  • 1. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
    Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
    Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long COVID and neuropsychiatric manifestations (Review).
    Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Smyrnis N; Rizos E
    Exp Ther Med; 2022 May; 23(5):363. PubMed ID: 35493431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
    Troyer EA; Kohn JN; Hong S
    Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations of long-COVID syndrome: a narrative review.
    Stefanou MI; Palaiodimou L; Bakola E; Smyrnis N; Papadopoulou M; Paraskevas GP; Rizos E; Boutati E; Grigoriadis N; Krogias C; Giannopoulos S; Tsiodras S; Gaga M; Tsivgoulis G
    Ther Adv Chronic Dis; 2022; 13():20406223221076890. PubMed ID: 35198136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.
    Magdy R; Elmazny A; Soliman SH; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassien A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Mohamed J; Hussein M
    J Headache Pain; 2022 Aug; 23(1):101. PubMed ID: 35962348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.
    Elmazny A; Magdy R; Hussein M; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassin A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Abdelbadie M; Soliman SH
    Eur Arch Psychiatry Clin Neurosci; 2023 Sep; 273(6):1349-1358. PubMed ID: 36707454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric aspects of long COVID: A comprehensive review.
    Kubota T; Kuroda N; Sone D
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):84-93. PubMed ID: 36385449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legacy of neuropsychiatric symptoms associated with past COVID-19 infection: A cause of concern.
    De Berardis D; Di Carlo F; Di Giannantonio M; Pettorruso M
    World J Psychiatry; 2022 Jun; 12(6):773-778. PubMed ID: 35978974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychiatric Aspects of COVID-19 - A Narrative Overview].
    Rittmannsberger H; Barth M; Malik P; Yazdi K
    Fortschr Neurol Psychiatr; 2022 Mar; 90(3):108-120. PubMed ID: 34341978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
    Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
    Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
    Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses.
    Banerjee D; Viswanath B
    Asian J Psychiatr; 2020 Dec; 54():102350. PubMed ID: 33271682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-COVID syndrome-Focus fatigue].
    Hellwig S; Domschke K
    Nervenarzt; 2022 Aug; 93(8):788-796. PubMed ID: 35606656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Outcomes and Sleep Dysfunction in COVID-19 Patients: Risk Factors and Mechanisms.
    Karkala A; Tzinas A; Kotoulas S; Zacharias A; Sourla E; Pataka A
    Neuroimmunomodulation; 2023; 30(1):237-249. PubMed ID: 37757765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of SARS-CoV-2 on neuropsychiatric disorders.
    Robinson-Agramonte MA; Gonçalves CA; Noris-García E; Préndes Rivero N; Brigida AL; Schultz S; Siniscalco D; García García RJ
    World J Psychiatry; 2021 Jul; 11(7):347-354. PubMed ID: 34327127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study.
    Du Y; Zhao W; Du L; Liu J
    Psychoradiology; 2021 Dec; 1(4):199-211. PubMed ID: 38666221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue versus COVID-19: Comparing the incidence of cardiovascular, neuropsychiatric, and autoimmune complications.
    Wee LE; Lim JT; Tan JYJ; Malek MIBA; Chiew C; Ng LC; Chia PY; Leo YS; Lye DC; Tan KB
    J Travel Med; 2024 Jun; ():. PubMed ID: 38864568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.